Additionally, favorable government policies and healthcare schemes enhance accessibility to diabetes management products in these cities, further driving market growth
In August, Lilly also introduced less-expensive versions of its lower doses of Zepbound that come in single-dose vials
Bone health is a fourth thats worth covering specifically for the AF population
It needs to be part of a comprehensive approach
It is also about how much of the molecule is bound to IGFBPs, how strongly it binds, and how much remains available for receptor interaction
The sole head-to-head comparison of these two also favors semaglutide, which brought about a 16% vs 6.4% reduction in body weight in a 68-week randomized controlled trial of 338 obese patients without diabetes (sponsored by semaglutides manufacturer) (Rubino DM et al, JAMA 2022;327(2):138150)